Federal prosecutors allege a Nevada physician received illegal kickbacks, bribes, and rebates, billed Medicare for medically unnecessary amniotic wound allografts, and falsified patient records.
The assay is indicated to identify patients with advanced melanoma who have BRAF V600E or BRAF V600K variants and may benefit from FDA-approved targeted therapies.
Accelerated approval is based on objective response rate and duration of response in advanced melanoma, with postapproval trials required to confirm clinical benefit.
A real‐world Brazilian registry suggests that challenges in biologic distribution were associated with treatment interruption, particularly among therapies requiring more frequent dosing.
Daily itch duration emerged as the strongest factor linking disease severity with quality of life, ahead of sleep disturbance, scratching frequency, and average itch intensity.
MDSpire News
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
A real-world cohort found faster early skin responses with ixekizumab than with guselkumab or ustekinumab following secukinumab treatment failure, while all three biologics demonstrated favorable safety.
Structured review highlights stronger evidence for platelet-rich plasma than for exosome-based and other emerging regenerative therapies while underscoring the need for standardized transplantation-specific research.
Voters will decide whether to expand lawmakers' authority to tax currently exempt healthcare goods and services, raising concerns about patient costs and healthcare access.
Researchers analyzed UK Biobank data to determine whether spending sedentary time in prolonged vs interrupted bouts was associated with subsequent cancer incidence and cancer mortality.